SG

Sangeeta Gupta

Active Director Director DIN 07516330
DIN 07516330 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Sangeeta Gupta

Data last updated:

Sangeeta Gupta is a Director at Remark Pharma Private Limited (since 2016). The company operates in Pharma. Remark Pharma Private Limited reported revenue of ₹49.6 Lakh (FY 2025).

DIN 07516330
Primary Designation Director
Industry Pharma
First Appointment 11 May 2016
Oldest Company Age 15 yrs
Largest company Remark Pharma Private Limited · ₹49.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remark Pharma Private Limited U24231JH2011PTC014896
Director11 May 20162011₹49.6 Lakh (FY 2025)Active

Board colleagues of Sangeeta Gupta

Directorship timeline

Open interactive timeline →
Remark Pharma Private Limited
Premium access

Shareholding and investment profile for Sangeeta Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeeta Gupta

Sangeeta Gupta currently holds 1 directorship: Remark Pharma Private Limited (Director, since 11 May 2016, revenue ₹49.6 Lakh (FY 2025)).

Sangeeta Gupta was first appointed on 11 May 2016 as Director at Remark Pharma Private Limited.

The current boards of Sangeeta Gupta's companies include Deepak Kumar (Remark Pharma Private Limited), Kanchan Arya (Remark Pharma Private Limited), Pawan Kumar Arya (Remark Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available